FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 02/01/2015 |
3. Issuer Name and Ticker or Trading Symbol
Bunge LTD [ BG ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock(1) | 1,689 | D | |
Common Stock | 3,058 | I | By DGK Living Trust |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (Right to Buy) | (2) | 02/27/2017 | Common Stock | 4,300 | $80.06 | D | |
Stock Option (Right to Buy) | (3) | 02/28/2018 | Common Stock | 3,450 | $110.745 | D | |
Stock Option (Right to Buy) | (4) | 03/03/2020 | Common Stock | 4,950 | $61.6 | D | |
Stock Option (Right to Buy) | (5) | 03/02/2021 | Common Stock | 4,200 | $71.2 | D | |
Stock Option (Right to Buy) | (6) | 02/28/2022 | Common Stock | 4,500 | $67.63 | D | |
Stock Option (Right to Buy) | (7) | 03/04/2023 | Common Stock | 3,600 | $74.33 | D | |
Stock Option (Right to Buy) | (8) | 02/27/2024 | Common Stock | 3,300 | $79.47 | D |
Explanation of Responses: |
1. Includes (i) 666 restricted stock units ("RSUs") that were granted to the insider on March 5, 2013 and 14 RSUs acquired pursuant to a dividend reinvestment feature under the 2009 Bunge Limited Equity Incentive Plan that will vest in equal installments on March 5, 2015 and March 5, 2016 and (ii) 1,000 RSUs that were granted to the insider on February 28, 2014 and 9 RSUs acquired pursuant to a dividend reinvestment feature that will vest in substantially equal installments on February 28, 2015, February 28, 2016, and February 28, 2017. One RSU is convertible into one share of BG common stock. |
2. This option became exercisable in three equal annual installments beginning on February 27, 2008. |
3. This option became exercisable in three equal annual installments beginning on February 28, 2009. |
4. This option became exercisable in three equal annual installments beginning on March 3, 2011. |
5. This option became exercisable in three equal annual installments beginning on March 2, 2012. |
6. This option is exercisable in three equal installments beginning on February 28, 2013. |
7. This option is exercisable in three equal installments beginning on March 5, 2014. |
8. This option is exercisable in three equal installments beginning on February 28, 2015. |
/s/ John Tropeano, Attorney-in-Fact | 02/10/2015 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |